UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000044891 |
|---|---|
| Receipt number | R000051258 |
| Scientific Title | Effect of Intraoperative Hemodynamics on Postoperative Myocardial Injury in Esophageal Cancer Surgery and Pancreaticoduodenectomy A Prospective Observational Study |
| Date of disclosure of the study information | 2021/09/01 |
| Last modified on | 2024/07/19 15:51:40 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effect of Intraoperative Hemodynamics on Postoperative Myocardial Injury in Esophageal Cancer Surgery and Pancreaticoduodenectomy A Prospective Observational Study
Acronym
Effect of Intraoperative Hemodynamics on Postoperative Myocardial Injury in Esophageal Cancer Surgery and Pancreaticoduodenectomy A Prospective Observational Study
Scientific Title
Effect of Intraoperative Hemodynamics on Postoperative Myocardial Injury in Esophageal Cancer Surgery and Pancreaticoduodenectomy A Prospective Observational Study
Scientific Title:Acronym
Effect of Intraoperative Hemodynamics on Postoperative Myocardial Injury in Esophageal Cancer Surgery and Pancreaticoduodenectomy A Prospective Observational Study
Region
| Japan |
Condition
Condition
Myocardial injury after surgery (MINS)
Classification by specialty
| Cardiology | Anesthesiology | Intensive care medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
to identify the factors affecting the occurrence and severity of myocardial injury after esophageal cancer surgery and pancreatoduodenectomy.
Basic objectives2
Others
Basic objectives -Others
To investigate the association between MINS and circulatory dynamics during surgery, and the selection of appropriate circulatory agonists
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
troponin T, blood pressure, heart rate
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients 18 years and older undergoing esophageal cancer surgery and pancreaticoduodenectomy
Key exclusion criteria
Cases that were converted to open surgery
Patients on dialysis
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | Naoya |
| Middle name | |
| Last name | Iwasaki |
Organization
Nagasaki University Graduate School of Biomedical Sciences
Division name
Department of Anesthesiology and Intensive Care Medicine
Zip code
852-8501
Address
1-7-1 Sakamoto, Nagasaki, Japan
TEL
095-819-7370
taiga@nagasaki-u.ac.jp
Public contact
Name of contact person
| 1st name | Naoya |
| Middle name | |
| Last name | Iwasaki |
Organization
Nagasaki University Graduate School of Biomedical Sciences
Division name
Department of Anesthesiology and Intensive Care Medicine
Zip code
852-8501
Address
1-7-1 Sakamoto, Nagasaki, Japan
TEL
095-819-7370
Homepage URL
n-iwasaki@nagasaki-u.ac.jp
Sponsor or person
Institute
Nagasaki university
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Clinical research senter, Ngasaki university hospital
Address
1-7-1 Sakamoto, Nagasaki, Japan
Tel
095-819-7370
rinshou7726@umin.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 09 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2021 | Year | 09 | Month | 01 | Day |
Date of IRB
| 2023 | Year | 04 | Month | 18 | Day |
Anticipated trial start date
| 2022 | Year | 09 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 10 | Month | 31 | Day |
Date of closure to data entry
| 2026 | Year | 03 | Month | 31 | Day |
Date trial data considered complete
Date analysis concluded
Other
Other related information
Single-center prospective observational study
Patients undergoing esophageal cancer surgery and pancreaticoduodenectomy at our hospital from September 1, 2022 to August 31, 2024 will be included in the study. Blood samples will be collected at 4 points before induction of anesthesia, after ICU admission, on postoperative day 1, and on postoperative day 3 to measure troponin T
Management information
Registered date
| 2021 | Year | 07 | Month | 17 | Day |
Last modified on
| 2024 | Year | 07 | Month | 19 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051258
